| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348568 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 02/19/2002 | US6348500 Increasing the sperm count in males |
| 02/19/2002 | US6348497 Prosthetic joints by reducing bone degradation |
| 02/19/2002 | US6348486 Methods for modulating bladder function |
| 02/19/2002 | US6348476 Ion exchange inhibitor for cardiovascular disorders |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348457 Antagonizing reserpine in mammals |
| 02/19/2002 | US6348448 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 02/19/2002 | US6348447 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 02/19/2002 | US6348444 Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348335 Metabolism active materials, heating and cooling yeasts then isolation |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348213 Intravenously administering liposomes having lipid component comprising phosphatidylcholine having same acyl chains as phosphatidylcholines in heart cells of younger subjects, repeating until drop in serum creatine phosphokinase is noted |
| 02/19/2002 | CA2204604C Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 02/19/2002 | CA2182030C Use of a bradykinin antagonist in a cosmetic, pharmaceutical or dermatological composition; composition thus obtained |
| 02/19/2002 | CA2082568C Amorphous (quinolin-2-ylmethoxy) indoles |
| 02/19/2002 | CA2023630C Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/19/2002 | CA2004461C Method for the stimulation of bone marrow cells |
| 02/18/2002 | CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 02/14/2002 | WO2002012537A2 Mutant trichosanthin |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012496A1 P53-dependent novel apoptosis-associated protein and method of screening apoptosis controlling agent |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012456A2 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | WO2002012448A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | WO2002012442A2 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | WO2002012260A1 Macrolide antibiotics |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012246A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012243A2 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012238A2 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012223A2 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012192A1 Quinolene derivatives as anti-inflammation agents |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012189A1 Fused bicyclic amide compounds and medicinal use thereof |
| 02/14/2002 | WO2002012188A2 Indole compounds useful for the treatment of cancer |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002011779A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| 02/14/2002 | WO2002011771A2 Contrast medium consisting of geometrically highly ordered proteins for medical diagnostics |
| 02/14/2002 | WO2002011766A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/14/2002 | WO2002011765A1 COMBINATION PREPARATION WITH AN ERβ SELECTIVE ESTROGEN AND A SERM OR ANTIESTROGEN |
| 02/14/2002 | WO2002011763A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 02/14/2002 | WO2002011760A1 Parenteral vaccine formulations and uses thereof |
| 02/14/2002 | WO2002011746A2 Chlorella preparations exhibiting immunomodulating properties |
| 02/14/2002 | WO2002011738A1 Cosmetics or dermatological preparations containing polymers having phosphorylcholine side chain |
| 02/14/2002 | WO2002011735A2 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 02/14/2002 | WO2002011733A1 Pharmaceutical composition comprising condensed indole compound |
| 02/14/2002 | WO2002011731A2 Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
| 02/14/2002 | WO2002011728A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 02/14/2002 | WO2002011727A1 Stable pergolide mesylate and process for making same |
| 02/14/2002 | WO2002011725A1 Inflammatory cytokine production inhibitors |
| 02/14/2002 | WO2002011724A2 Neuroprotective 2-pyridinamine compositions and related methods |
| 02/14/2002 | WO2002011722A1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom |
| 02/14/2002 | WO2002011719A2 Lipase inhibitors for the treatment of dyspepsia |
| 02/14/2002 | WO2002011718A1 IgE PRODUCTION INHIBITORS |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO2002011713A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 02/14/2002 | WO2002011710A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 02/14/2002 | WO2002011706A2 Drugs for sex dysfunctions |
| 02/14/2002 | WO2002011705A2 Composition for combined use of aromatase inhibitors |
| 02/14/2002 | WO2002011704A2 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases |
| 02/14/2002 | WO2002011677A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/14/2002 | WO2002011676A2 Method of using diketopiperazines and composition containing them |
| 02/14/2002 | WO2002011665A2 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 02/14/2002 | WO2002011551A2 Oil/fat composition |
| 02/14/2002 | WO2002011513A1 A novel polypeptide-human ehd protein 9.57 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002011512A1 Novel polypeptide--the human mitochonrial cadherin 10.12 and polynucleotide encoding it |
| 02/14/2002 | WO2001098471A8 Human phosphodiesterases |
| 02/14/2002 | WO2001076531A3 Bile acid containing prodrugs with enhanced bioavailability |
| 02/14/2002 | WO2001068663B1 Nucleoside compounds and uses thereof |
| 02/14/2002 | WO2001068603A3 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |